The objective of this study was to characterize the kinetics of the cellular and humoral
immune responses elicited by measles vaccine given to previously immune adults. The …

The present investigation was done to determine whether measles enzyme immune assay
(EIA) absorbency values were lower in women born in the vaccine era after 1963 and their …

Quantitative serologic responses following the inoculation of infants less than one year of
age with live, further-attenuated measles virus vaccine were compared to those of infants …

In 1964, the Medical Research Council undertook a trial of measles vaccine in over 36000
United Kingdom children; 9577 of whom received live vaccine, 10625 received inactivated …

During a large outbreak of measles in Ohio in 1976 it was possible to measure measles
vaccine efficacy by age at time of vaccination and number of years since vaccination. Using …

In 1982 a two dose regimen was introduced in Sweden for the combined vaccination against
measles, mumps, and rubella of children aged 18 months and 12 years. Since 1977 about …

Combined measles, mumps, and rubella vaccination is soon to become available in Britain
in the routine immunisation programme. A controlled study was performed in 319 children …

Background The majority of infants will not be protected by maternal antibodies until their
first measles vaccination, between 12 and 15 months of age. This provides incentive to …

Background. Maternally derived passive measles antibody may interfere with vaccine-
induced immunity in infants less than 12 months of age. However, early loss of passive …

General vaccination with a combined measles, mumps, and rubella vaccine was introduced
in Sweden in 1982. The immunisation schedule comprises two vaccine injections, given at …